News Headline Summary
FDA advisory panel vote 18 to 0 for J&J drug
- Data supports the efficacy of J&J drug Bedaquiline against resistant TB.
Reaction details (20:57)
- No immediate reaction to the news, last trade at USD 69.25 (+0.65%).
28 Nov 2012 - 20:55
Subscribe Now to RANsquawk
Click here for a 1 week free trial
RANsquawk provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
Teams of analysts covering equities, fixed income, FX, energy, and metals markets
Real-time scrolling news service with instant analysis
Daily and weekly pre-market research and calendars
Video updates covering near-term key risk events & primary trading themes
One-to-one chat with our expert analysts